Loading...
Medley, Inc.
4480.T•JPX
Healthcare
Medical - Healthcare Information Services
¥3140.00
¥50.00(1.62%)
Medley, Inc. (4480.T) Financial Performance & Income Statement Overview
Review Medley, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
42.71%
↑ 42.71%
Operating Income Growth
-12.59%
↓ 12.59%
Net Income Growth
9.04%
↑ 9.04%
Operating Cash Flow Growth
-36.79%
↓ 36.79%
Operating Margin
6.22%
↑ 6.22%
Gross Margin
64.20%
↑ 64.20%
Net Profit Margin
7.16%
↑ 7.16%
ROE
11.59%
↑ 11.59%
ROIC
5.36%
↑ 5.36%
Medley, Inc. (4480.T) Income Statement & Financial Overview
Review Medley, Inc.'s (4480.T) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $7.66B | $6.94B | $8.76B | $5.95B |
| Cost of Revenue | $2.73B | $2.62B | $2.60B | $2.43B |
| Gross Profit | $4.93B | $4.32B | $6.16B | $3.51B |
| Gross Profit Ratio | $0.64 | $0.62 | $0.70 | $0.59 |
| R&D Expenses | $0.00 | $0.00 | $9.00M | $5.00M |
| SG&A Expenses | $4.96B | $4.22B | $4.14B | $3.27B |
| Operating Expenses | $4.96B | $4.22B | $4.15B | $3.27B |
| Total Costs & Expenses | $7.69B | $6.84B | $6.75B | $5.70B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $15.00M | $3.00M |
| Depreciation & Amortization | $419.00M | $164.75M | $422.00M | $193.00M |
| EBITDA | $388.00M | $261.75M | $2.46B | $922.00M |
| EBITDA Ratio | $0.05 | $0.04 | $0.28 | $0.16 |
| Operating Income | -$32.00M | $97.00M | $2.01B | $243.00M |
| Operating Income Ratio | -$0.004 | $0.01 | $0.23 | $0.04 |
| Other Income/Expenses (Net) | $372.00M | $464.00M | $431.00M | $482.00M |
| Income Before Tax | $340.00M | $561.00M | $2.44B | $725.00M |
| Income Before Tax Ratio | $0.04 | $0.08 | $0.28 | $0.12 |
| Income Tax Expense | -$91.00M | $277.00M | $879.00M | $228.00M |
| Net Income | $474.00M | $315.00M | $1.54B | $466.00M |
| Net Income Ratio | $0.06 | $0.05 | $0.18 | $0.08 |
| EPS | $14.52 | $9.63 | $47.09 | $14.37 |
| Diluted EPS | $14.51 | $9.63 | $47.06 | $14.28 |
| Weighted Avg Shares Outstanding | $32.71M | $32.70M | $32.75M | $32.42M |
| Weighted Avg Shares Outstanding (Diluted) | $32.73M | $32.70M | $32.77M | $32.64M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan